Jinyong Kim

Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment

S. Im, P. G. Choe, M. Oh, 2022, The oncologist.

Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer

S. Im, M. Oh, W. Park, 2022, Frontiers in Immunology.

Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations

S. Im, Kwangsoo Kim, Kyung-Hun Lee, 2023, Human Genomics.

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms

Junshik Hong, Sung-Soo Yoon, Inho Kim, 2021, Scientific Reports.

HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results

Jiwon Koh, Jinyong Kim, Kyung-Hun Lee, 2023, Breast cancer research : BCR.

Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea

Soobok Joe, Jin-Young Lee, Tae-You Kim, 2023, BMB reports.